Zacks Investment Research on MSN
Wall Street analysts think Assertio (ASRT) could surge 249.87%: Read this before placing a bet
Assertio (ASRT) closed the last trading session at $11.13, gaining 4.3% over the past four weeks, but there could be plenty ...
Insider selling in Assertio raises red flags and erodes trust in management's statements. The magnitude and frequency of insider sales cast doubt on the company's trajectory and prompt a cautious ...
$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
The average one-year price target for Assertio Holdings (NasdaqCM:ASRT) has been revised to $38.19 / share. This is an ...
Assertio Holdings has experienced extreme price volatility, but the current price presents a buying opportunity. The company has diversified its pharmaceutical portfolio and improved its financial ...
ASSERTIO THERAPEUTICS ($ASRT) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of -$0.11 per share, missing estimates of -$0. ...
Here is how Assertio (ASRT) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results